Wednesday, November 30, 2022: M&A

Horizon Therapeutics PLC is hearing buyout offers from pharmaceutical companies Amgen Inc., Johnson & Johnson’s Janssen Global Services LLC, and Sanofi. Horizon, which makes medicines for rare and immune diseases, had a market value of $18 billion as of...

Wednesday, November 30, 2022: Mental Health

New York City Mayor Eric Adams unveiled a new plan to remove people with severe, untreated mental illness from city streets and subways. Under the plan, New York City agencies – such as the New York Police Department and New York City Fire Department – and emergency...

Wednesday, November 30, 2022: Providers

The Centers for Medicare & Medicaid Services (CMS) published a memo reminding hospitals of their responsibility to protect patients and health care workers from physical violence in the workplace. The memo said hospitals should be able to demonstrate their...

Tuesday, November 29, 2022: Life Sciences

Research published in JAMA Internal Medicine revealed that Food and Drug Administration (FDA) approvals of “skinny labels” on biosimilars saved Medicare over $1 billion over five years. According to the research, the FDA approved 33 biosimilars based on 11...